Cocaine withdrawal symptoms identify "Type B" cocaine-dependent patients

American Journal on Addictions

Volumn 17, Issue 1, 2008, Pages 60-64

  Ahmadi, Jamshid ^a,b,c   Kampman, Kyle ^a   Dackis, Charles ^a   Sparkman, Thorne ^a   Pettinati, Helen ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; COCAINE DEPENDENCE; COCAINE SELECTIVE SEVERITY ASSESSMENT; COMORBIDITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PSYCHOSOCIAL CARE; SCORING SYSTEM; SUBSTANCE ABUSE; VIOLENCE; WITHDRAWAL SYNDROME;

COCAINE; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; DRUG THERAPY; FEMALE; HUMANS; MALE; MASS SCREENING; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 38549171740     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490701755999     Document Type: Article

References (21)

1. Kampman K, Volpicelli JR, McGinnis DE, et al. Reliability and validity of the cocaine selective severity assessment. Addict Behav. 1998;23:449-461.
2. Kampman K, Alterman AI, Volpicelli JR, et al. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav. 2001;15:52-59.
3. Kampman K, Pettitnati H, Volpicelli JR, et al. Cocaine dependence severity predicts outcome in outpatients detoxification from cocaine and alcohol. Am J Addict. 2004;13:74-82.
4. Mulvaney F, Alterman AI, Boardman CR, Kampman K. Cocaine abstinence symptomatology and treatment attrition. J Subst Abuse Treat. 1999;16:129-135.
5. Babor TF, Hofmann M, DelBoca FK, et al. Types of alcoholics, I: evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry. 1992;49:599-608.
6. Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science. 1987;236:410-416.
7. Ball DM, Sharman D, Gibb R, Powell JF, Hillman A, Peters T, Murray R, Smith I. Association Between the C2 allele at the cytochrome P450IIE1 gene and alcohol induced liver disease, alcohol Korsakoff's syndrome or alcohol dependence syndrome. Drug Alcohol Depend. 1995 Oct;39(3):181-184.
8. Kranzler H, Lappalainen J, Nellissery M, Gelernter J. Association study of alcoholism subtypes with a functional promoter polymorphism in the serotonin transporter protein gene. Alcohol Clin Exp Res. 2002;26:1330-1335.
9. Pettinati HM. The use of selective serotonone reuptake inhibitors in treating alcoholic subtypes. J Clin Psychiatry. 2001;62 (Suppl. 20):26-31.
10. Goveas JS, Csernansky JG, Coccaro EF. Platelet serotonin content correlates inversely with life history of aggression in personality-disordered subjects. Psychiatry Res. 2004;126:23-32.
11. Buydens-Branchey L, Branchey M, Hudson J, Rothman M, Fergeson P, McKernin C. Serotonergic function in cocaine addicts: prolactin responses to sequential D,L-fenfluramine challenges. Biol Psychiatry. 1999;45:1300-1306.
12. Patkar AA, Berrettini WH, Mannelli P, et al. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers. Psychiatr Genet. 2004;14:25-32.
13. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders - Subject Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department New York State Psychiatric Institute; 1996.
14. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ, eds. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, New Jersey: Humana Press; 1992:41-72.
15. Kampman K, Volpicelli JR, Mulvaney F, et al. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav. 2002;27:251-260.
16. Pettinati HM, Volpicelli JR, Kranzler HR, Luck G, Rukstalis MR, Cnaan A. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res. 2000;24:1041-1049.
17. Kranzler HR, Burleson JA, Brown J, Babor TF. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin Exp Res. 1996;20:1534-1541.
18. Johnson BA, Roache JD, Javors MA, et al. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. JAMA. 2000;284:963-971.
19. Batki SL, Manfredi LB, Jacob P III, Jones RT. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol. 1994;14:360-361.
20. Grabowski J, Rhoades H, Elk R, et al. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. J Clin Psychopharmacol. 1995;15:163-174.
21. Winhusen TM, Somoza EC, Harrer JM, et al. A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction. 2005;100 (Suppl. 1):68-77.